GE HealthCare Technologies (GEHC) Research & Development (2022 - 2026)

GE HealthCare Technologies' Research & Development history runs 5 years deep, the most recent figure standing at $345.0 million for Q1 2026.

• Quarterly Research & Development changed 0.29% year-over-year to $345.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 billion (down 5.18% YoY) and the FY2025 annual result came in at $1.3 billion, down 3.89% from the prior year.
• Research & Development was $345.0 million for Q1 2026 at GE HealthCare Technologies, up from $323.0 million in the prior quarter.
• Across five years, Research & Development topped out at $345.0 million in Q1 2026 and bottomed at $238.0 million in Q1 2022.
• A 5-year average of $302.8 million and a median of $315.0 million in 2023 frame the typical range for Research & Development.
• Annual changes were most pronounced in 2023 — Research & Development grew 23.85% — and 2025, when it declined 7.65%.
• GE HealthCare Technologies' Research & Development stood at $271.0 million in 2022, then gained by 16.24% to $315.0 million in 2023, then gained by 9.21% to $344.0 million in 2024, then fell by 6.1% to $323.0 million in 2025, then climbed by 6.81% to $345.0 million in 2026.
• Business Quant data shows GEHC's Research & Development at $345.0 million in Q1 2026, $323.0 million in Q4 2025, and $292.0 million in Q3 2025.